Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Severe asthma: an expanding and mounting clinical challenge.

Bell MC, Busse WW.

J Allergy Clin Immunol Pract. 2013 Mar;1(2):110-21; quiz 122. doi: 10.1016/j.jaip.2013.01.005. Review.

2.

Omalizumab for asthma in adults and children.

Normansell R, Walker S, Milan SJ, Walters EH, Nair P.

Cochrane Database Syst Rev. 2014 Jan 13;(1):CD003559. doi: 10.1002/14651858.CD003559.pub4. Review.

PMID:
24414989
3.

Treating Moderate-to-Severe Allergic Asthma with a Recombinant Humanized Anti-IgE Monoclonal Antibody (Omalizumab).

D'Amato G, Bucchioni E, Oldani V, Canonica W.

Treat Respir Med. 2006;5(6):393-8.

PMID:
17154668
4.

Long-term omalizumab treatment in severe allergic asthma: the South-Eastern Mediterranean "real-life" experience.

Tzortzaki EG, Georgiou A, Kampas D, Lemessios M, Markatos M, Adamidi T, Samara K, Skoula G, Damianaki A, Schiza S, Tzanakis N, Siafakas NM.

Pulm Pharmacol Ther. 2012 Feb;25(1):77-82. doi: 10.1016/j.pupt.2011.11.004.

PMID:
22155001
5.

Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab).

Milgrom H, Berger W, Nayak A, Gupta N, Pollard S, McAlary M, Taylor AF, Rohane P.

Pediatrics. 2001 Aug;108(2):E36.

PMID:
11483846
6.

Anti-IgE therapy with omalizumab for severe asthma: current concepts and potential developments.

Pelaia G, Vatrella A, Busceti MT, Gallelli L, Terracciano R, Maselli R.

Curr Drug Targets. 2015;16(2):171-8. Review.

PMID:
25523898
7.

Omalizumab decreases exacerbation frequency, oral intake of corticosteroids and peripheral blood eosinophils in atopic patients with uncontrolled asthma.

Pelaia G, Gallelli L, Romeo P, Renda T, Busceti MT, Proietto A, Grembiale RD, Marsico SA, Maselli R, Vatrella A.

Int J Clin Pharmacol Ther. 2011 Dec;49(12):713-21.

PMID:
22122813
8.

Effect of omalizumab as add-on therapy on asthma-related quality of life in severe allergic asthma: a Brazilian study (QUALITX).

Rubin AS, Souza-Machado A, Andradre-Lima M, Ferreira F, Honda A, Matozo TM; QUALITX Study Investigators..

J Asthma. 2012 Apr;49(3):288-93. doi: 10.3109/02770903.2012.660297.

PMID:
22356355
9.

Omalizumab for the treatment of severe persistent allergic asthma in children aged 6-11 years: a NICE single technology appraisal.

Burch J, Griffin S, McKenna C, Walker S, Paton J, Wright K, Woolacott N.

Pharmacoeconomics. 2012 Nov 1;30(11):991-1004. doi: 10.2165/11597160-000000000-00000. Review.

PMID:
22950547
10.

Anti-IgE for chronic asthma in adults and children.

Walker S, Monteil M, Phelan K, Lasserson TJ, Walters EH.

Cochrane Database Syst Rev. 2004;(3):CD003559. Review. Update in: Cochrane Database Syst Rev. 2006;(2):CD003559.

PMID:
15266491
11.

A study into efficacy of omalizumab therapy in patients with severe persistent allergic asthma at a tertiary referral centre for asthma in Ireland.

Subramaniam A, Al-Alawi M, Hamad S, O'Callaghan J, Lane SJ.

QJM. 2013 Jul;106(7):631-4. doi: 10.1093/qjmed/hct072.

PMID:
23550166
13.

Omalizumab in the treatment of asthma.

Tan R, Corren J.

Expert Rev Respir Med. 2011 Dec;5(6):747-56. doi: 10.1586/ers.11.73. Review.

PMID:
22082161
14.

Omalizumab: a monoclonal anti-IgE antibody.

Belliveau PP.

MedGenMed. 2005 Jan 27;7(1):27. Review.

15.

Concomitant asthma medications in moderate-to-severe allergic asthma treated with omalizumab.

Chen H, Eisner MD, Haselkorn T, Trzaskoma B.

Respir Med. 2013 Jan;107(1):60-7. doi: 10.1016/j.rmed.2012.09.008.

16.

Targeting IgE in asthma.

Kuhl K, Hanania NA.

Curr Opin Pulm Med. 2012 Jan;18(1):1-5. doi: 10.1097/MCP.0b013e32834deebb. Review.

PMID:
22139745
17.

[Retrospective analysis of omalizumab in patients with severe allergic asthma].

Padullés Zamora N, Comas Sugrañes D, Méndez Cabaleiro N, Figueras Suriol A, Jodar Masanes R.

Farm Hosp. 2013 Sep-Oct;37(5):399-405. doi: 10.7399/FH.2013.37.5.728. Spanish.

18.

Therapy with omalizumab for patients with severe allergic asthma improves asthma control and reduces overall healthcare costs.

Costello RW, Long DA, Gaine S, Mc Donnell T, Gilmartin JJ, Lane SJ.

Ir J Med Sci. 2011 Sep;180(3):637-41. doi: 10.1007/s11845-011-0716-2.

PMID:
21557095
19.

The role of omalizumab in the treatment of severe allergic asthma.

Chapman KR, Cartier A, Hébert J, McIvor RA, Schellenberg RR.

Can Respir J. 2006 Jul-Aug;13 Suppl B:1B-9B. Review.

20.

Comprehensive efficacy of omalizumab for severe refractory asthma: a time-series observational study.

Tajiri T, Niimi A, Matsumoto H, Ito I, Oguma T, Otsuka K, Takeda T, Nakaji H, Inoue H, Iwata T, Nagasaki T, Kanemitsu Y, Izuhara Y, Mishima M.

Ann Allergy Asthma Immunol. 2014 Oct;113(4):470-5.e2. doi: 10.1016/j.anai.2014.06.004.

PMID:
24994694
Items per page

Supplemental Content

Support Center